Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents and Short-Term Investments (Tables)

Cash, Cash Equivalents and Short-Term Investments (Tables)

9 Months Ended

Sep. 30, 2017

Cash, Cash Equivalents and Short-Term Investments

Schedule of cash, cash equivalents and short-term investments

Cash, cash equivalents and short-term investments consisted of the following (in thousands):


	September 30,		December 31,
	2017		2016
Cash	$	385	$	240
Money market funds		5,099		9,496
U.S. treasury bills		3,000		4,300
Government-sponsored enterprise securities		3,655		16,459
Corporate bonds and commercial paper		55,937		44,271
	$	68,076	$	74,766
Reported as:
Cash and cash equivalents	$	25,879	$	17,632
Short-term investments		42,197		57,134
	$	68,076	$	74,766

Schedule of cash equivalents and short-term investments including the securities with unrealized gains and losses

Cash equivalents and short-term investments include the following securities with gross unrealized gains and losses (in thousands):


			Gross		Gross
	Amortized		Unrealized		Unrealized
September 30, 2017	Cost		Gains		Losses		Fair Value
U.S. treasury bills	$	3,000	$	—	$	—	$	3,000
Government-sponsored enterprise securities		3,656		—		(1)		3,655
Corporate bonds and commercial paper		55,943		—		(6)		55,937
Total	$	62,599	$	—	$	(7)	$	62,592


			Gross		Gross
	Amortized		Unrealized		Unrealized
December 31, 2016	Cost		Gains		Losses		Fair Value
U.S. treasury bills	$	4,300	$	—	$	—	$	4,300
Government-sponsored enterprise securities		16,457		3		(1)		16,459
Corporate bonds and commercial paper		44,291		2		(22)		44,271
Total	$	65,048	$	5	$	(23)	$	65,030

Schedule of fair value and gross unrealized losses of the entity's investments in unrealized loss position

The following table shows the fair value and gross unrealized losses of our investments in individual securities that are in an unrealized loss position, aggregated by investment category (in thousands):


September 30, 2017	Fair Value		Unrealized Losses
Government-sponsored enterprise securities	$	3,655	$	(1)
Corporate bonds and commercial paper		22,269		(6)
Total	$	25,924	$	(7)